Accessibility Menu
 

How a Conference Caused Bluebird Bio's Shares to Rocket 33% in June

A presentation at the influential American Society of Clinical Oncology in early June fueled optimism in the clinical-stage biotech company.

By Todd Campbell Updated Jul 5, 2017 at 10:31PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.